Skip to content
NeuroTechGuide

Belgium's ReVision Implant gets FDA Breakthrough designation for a visual cortex prosthesis

The Occular system pairs a headset camera with a brain implant to target blindness that retinal implants can't treat.

In briefRegulationImplants

Belgian start-up ReVision Implant has received FDA Breakthrough Device designation for Occular, a visual prosthesis that stimulates the visual cortex directly. A wireless head-mounted camera feeds images that the implant turns into stimulation patterns. Because it bypasses the eye and optic nerve, it could help people with blindness that retinal implants can’t treat. The company plans a short-term clinical study in late 2026 and early human trials around mid-2027.

Cortical vision prostheses are drawing growing interest, including Neuralink’s Blindsight and Cortigent’s Orion.

Learn more: Visual prosthesis · Breakthrough Device designation

Share:XLinkedInBlueskyEmail

More news